Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Dana-Farber Cancer Institute Stories

2012-08-14 06:26:08

WEST CHESTER, Pa., Aug. 14, 2012 /PRNewswire/ -- Setting trends is nothing new for creative director and style icon Nicole Richie. This year, she will inspire more than just fashion through her involvement with QVC Presents "FFANY Shoes on Sale." Richie is scheduled to appear in both print and television public service announcements supporting the 19th annual breast cancer fundraising event. ( ) The charitable shoe sale, which is scheduled to be broadcast live on QVC Wednesday, October 24,...

2012-08-03 06:22:21

CANTON, Mass., Aug. 3, 2012 /PRNewswire/ -- For the 20(th) year, Dunkin' Donuts, America's all-day, everyday stop for coffee and baked goods, will support Dana-Farber Cancer Institute and the Jimmy Fund in its global fight against cancer. New England Dunkin' Donuts franchisees are committed to the Jimmy Fund, having raised $10.7 million since 1992. This year, Dunkin' Donuts will continue to support the Jimmy Fund through several fundraising events and campaigns in August. From August 4...

2012-07-22 06:20:19

Findings could enable individualized treatment for patients with medulloblastoma BOSTON, July 22, 2012 /PRNewswire-USNewswire/ -- Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and several collaborating institutions have linked mutations in specific genes to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children. The discovery, reported July in the journal Nature, provides doctors with potential biomarkers for...

2012-07-11 14:47:35

A new drug combination could offer hope to children with neuroblastoma — one of the deadliest forms of childhood cancer — by boosting the effectiveness of a promising new gene-targeted treatment. Researchers at The Institute of Cancer Research in London have found a way to overcome the resistance of cancer cells to a drug called crizotinib, which recently showed positive early results in its first trial in children with cancer. Crizotinib has already been licensed by the US...

2012-06-14 14:21:07

Bringing HOPE Home to Your Living Room through USTREAM on Tuesday, June 19, 2012, 5:30 p.m. PDT Online Excerpt: 5:45 Howietta: I am hugging Jennifer but she does not know it 5:59 bclements: I am humbled to be a part of this... 6:15 DianeJ775: I feel so special...oh wait...I am 6:32 nitalou: This is the easiest livestream I've ever participated in SAN FRANCISCO, June 14, 2012 /PRNewswire-USNewswire/ -- "There's a breast cancer support group on every corner you turn in the world,"...

2012-06-05 06:26:17

Ranked in the Top 4 in all 10 Specialty Areas BOSTON, June 5, 2012 /PRNewswire-USNewswire/ -- Boston Children's Hospital ranks first in the U.S. News & World Report's 2012-13 Best Children's Hospitals Rankings Honor Roll. With evaluation results released today, Boston Children's is first in Cardiology & Heart Surgery, Nephrology, Neurology & Neurosurgery; second in Cancer, Diabetes & Endocrinology, Gastroenterology and Urology; third in Neonatology and Orthopedics; and...

2012-06-05 02:28:49

- New $11 million True Family Women's Cancer Center, which was entirely funded through donations, to provide coordinated cancer care to women throughout the Puget Sound region SEATTLE, June 5, 2012 /PRNewswire-USNewswire/ -- Swedish Cancer Institute (SCI) opens its new True Family Women's Cancer Center to patients today. Carefully designed with the female cancer patient in mind, the new 23,600-square-foot women's cancer center gives Swedish Cancer Institute the ability to consolidate...

2012-06-04 02:26:04

INDIANAPOLIS, June 4, 2012 /PRNewswire/ -- The Board of Directors of Eli Lilly and Company (NYSE:LLY) has elected William G. Kaelin Jr., M.D. as a new member, effective June 4, 2012. Dr. Kaelin, 54, is a Professor in the Department of Medicine at Dana-Farber Cancer Institute and Brigham and Women's Hospital, Senior Physician at Brigham and Women's Hospital, and Associate Director, Basic Science, at the Dana-Farber/Harvard Cancer Center. As a member of Lilly's board, Dr. Kaelin will serve on...

2012-05-30 08:35:20

Scientists build a synthetic peptide that overcomes cancer cells´ survival defenses Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment. The strategy could pave the way for much needed new therapies to treat relapsed and refractory blood cancers, which are difficult to...

2012-05-17 12:19:23

A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago. The phase II clinical trial, led by investigators at Dana-Farber Cancer Institute and other research centers, examined the use...